Gowling WLG advised Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF). Innocan Pharma Corporation had closed its private placement of common shares and warrants to purchase…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
